RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
MOORE CAPITAL MANAGEMENT, LP 100,000$765,0000.01%
Private Capital Advisors, Inc. 45,370$2400.01%
CREDIT SUISSE AG/ 1,686,886$12,904,6780.01%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 173,309$1,3260.01%
CAPTRUST FINANCIAL ADVISORS 413,314$3,161,8550.01%
China Universal Asset Management Co., Ltd. 5,237$400.01%
Wedmont Private Capital 16,943$114,5350.01%
ALPS ADVISORS INC 156,214$1,195,0370.01%
DARK FOREST CAPITAL MANAGEMENT LP 17,561$134,3420.01%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 29,548$226,0430.01%
TWO SIGMA INVESTMENTS, LP 392,325$3,001,2860.01%
PITCAIRN CO 11,745$89,8490.01%
GenTrust, LLC 15,000$114,7500.01%
FMR LLC 10,689,532$81,774,9160.01%
Mitsubishi UFJ Trust & Banking Corp 349,470$2,673,4460.01%
Centiva Capital, LP 36,554$279,6380.01%
Vident Advisory, LLC 27,149$207,6900.01%
BALDWIN BROTHERS LLC/MA 7,336$56,1200.01%
Foundations Investment Advisors, LLC 22,107$169,1190.01%
STATE STREET CORP 11,757,088$89,941,7230.01%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.